Here's Why You Should Consider Buying Alvotech (ALVO) Stock [Yahoo! Finance]
Alvotech (ALVO)
Company Research
Source: Yahoo! Finance
The year 2024 has been transformational for Alvotech as it marked a gradual transition of ALVO from an R&D company into a full-scale global commercial biologic company. The company recently gained approval for some key biosimilar products like AVT04, its biosimilar to J&J 's JNJ blockbuster immunology drug, Stelara, and AVT02, its biosimilar to AbbVie 's ABBV blockbuster immunology drug Humira. Alvotech has a commercialization partnership with Teva Pharmaceuticals TEVA in the United States. The brand names of AVT04 and AVT02 are Selarsdi and Simlandi, respectively, in the United States. J&J's Stelara will lose patent exclusivity in the United States next year. AbbVie's Humira lost patent protection in the United States last January. Simlandi was approved in February 2024 and launched in May in the United States. Alvotech claims that AVT02 is a high-concentration interchangeable biosimilar to the reference product and has received exclusivity for its approved strengths in the U.S.
Show less
Read more
Impact Snapshot
Event Time:
ALVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ALVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ALVO alerts
High impacting Alvotech news events
Weekly update
A roundup of the hottest topics
ALVO
News
- Alvotech Receives Conversion Notices for Majority of Convertible Bonds [Yahoo! Finance]Yahoo! Finance
- Alvotech Receives Conversion Notices for Majority of Convertible BondsGlobeNewswire
- Are Medical Stocks Lagging Alvotech (ALVO) This Year? [Yahoo! Finance]Yahoo! Finance
- These Stocks Are Moving the Most Today: Nvidia, Super Micro, Trump Media, Pool, SolarEdge, FedEx, and More [Yahoo! Finance]Yahoo! Finance
- Alvotech and Advanz Pharma Sign Commercialization Agreement for Proposed Biosimilar to Eylea® LD/HD in Europe [Yahoo! Finance]Yahoo! Finance
ALVO
Earnings
- 5/21/24 - Miss
ALVO
Sec Filings
- 6/26/24 - Form RW
- 6/26/24 - Form 6-K
- 6/18/24 - Form 6-K
- ALVO's page on the SEC website